FLNA Stock Summary and Trading Ideas (Filana Therapeutics | NASDAQ:FLNA)

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

What symbol and exchange does Filana Therapeutics shares trade?

Filana Therapeutics trades on the NASDAQ stock market under the symbol FLNA.

What is Filana Therapeutics stock price doing today?

As of June 2, 2026, FLNA stock price declined to $1.44 with 373,913 million shares trading.

How much is Filana Therapeutics worth?

FLNA has a market cap of $69.56 million. This is considered a Micro Cap stock.

What are the top ETFs holding Filana Therapeutics?

The top ETF exchange traded funds that FLNA belongs to (by Net Assets): VTI, VXF, VHT, IWC, QQQS.

What are the support and resistance levels for Filana Therapeutics (FLNA)?

FLNA support price is $1.42 and resistance is $1.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FLNA shares will trade within this expected range on the day.